Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients

Obstetrical and Gynecological Survey - United States
doi 10.1097/00006254-200001000-00018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Erratum To: Prospective, Long-Term Study of the Effect of Cabergoline on Valvular Status in Patients With Prolactinoma and Idiopathic Hyperprolactinemia

Endocrine
2016English

Cabergoline Treatment in Acromegaly: Pros

Endocrine
2014English

Cabergoline Treatment in Acromegaly: Cons

Endocrine
2014English

Management of Hyperprolactinemia in Patients Receiving Antipsychotics.

CNS Spectrums
PsychiatryMental HealthNeurology
2004English

Psychological Effects of Dopamine Agonist Treatment in Patients With Hyperprolactinemia and Prolactin Secreting Adenomas

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

A Prospective Study of Cardiac Valvular Status in Patients Treated With Cabergoline for Endocrine Disease

Annales d'Endocrinologie
MedicineEndocrinologyMetabolismDiabetes
2012English

Safety of Long-Term Treatment With Cabergoline on Cardiac Valve Disease in Patients With Prolactinomas

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2013English

Anti-Thyroid Antibodies in Patients With Hyperprolactinemia.

Endocrinologia Japonica
1991English

Hyperprolactinemia: Diagnosis and Treatment Principles

Medicinski Casopis
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy